Targeting a key gene before birth could someday help lead to a treatment for Down syndrome by reversing abnormal embryonic brain development and improving cognitive function after birth, according to a Rutgers-led study by researchers at Rutgers-New Brunswick and Rutgers Robert Wood Johnson Medical School.
Recent Posts
- NJ ACTS Clinical Research Coordination Badge October Cohort Now Open!
- Pocket Ultrasound Reduces Hospital Stays for Patients with Shortness of Breath.
- Researchers Find Medicaid Is Crucial to Access Treatment for Opioid Addiction.
- New Charts for Artery Stiffness Could Flag Heart Risk Long Before Symptoms.
- When It Comes to Breastfeeding, Study Shows Timing Is an Important Consideration.
Categories
- Community (2,342)
- Covid (991)
- CTO Events (6)
- News (2,978)
- Pilots (21)